Development and provision of pharmaceutical solutions focusing on microbiota care, women's health, and orphan diseases.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
MicroPort
B
Development and provision of innovative medical devices and technical solutions to improve patient care globally.
Baxter
B
Development and provision of medical and technological solutions for healthcare professionals and patients, including primary care, hospital care, surgical care, and kidney care products.
URGO Group
B
Development of innovative medical solutions, specializing in wound care, public health, and treatment of complex pathologies.
Initiatives identified among leaders
Fixation d'objectifs pour réduire les émissions de GES
“Baxter fixe des objectifs pour réduire les émissio...” - BaxterMise en place d'un système de gestion des risques
“Microport crm met en place un système de gestion d...” - MicroPortFormation des professionnels de santé à travers la Fondation URGO
“La Fondation URGO soutient des projets de santé po...” - URGO Group62% of similar organizations communicate on CSR issues
+4895 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports